Monday 8th May 2023 |
Text too small? |
Auckland International Airport Limited (“Auckland Airport”) confirmed today that it is offering up to NZ$100,000,000 of five and a half year fixed rate bonds (with the ability to accept up to NZ$50,000,000 in oversubscriptions at Auckland Airport’s discretion) (the “Bonds”) to New Zealand retail investors and to institutional investors.
The offer opens today and will be made pursuant to the Financial Markets Conduct Act 2013 as an offer of debt securities of the same class as existing quoted debt securities. The notice required by the Financial Markets Conduct Regulations 2014 has been provided to NZX and is attached. The Bonds are expected to be quoted on the NZX Debt Market.
Full details of the bond issue are contained in the terms sheet which has been prepared for the offer and is attached.
The offer will open with an indicative margin range of 1.00 per cent to 1.05 per cent per annum and the Bonds will mature on 17 November 2028. An announcement of the actual margin and the interest rate on the Bonds will be made following the conclusion of the bookbuild process, which is expected to be on 10 May 2023. The terms sheet will be updated to include the interest rate and will be released on the same day.
The Bonds are expected to be assigned a long term credit rating of A- by S&P Global Ratings.
There is no public pool for the offer, with 100 per cent of the Bonds reserved for clients of BNZ and Westpac (as Joint Lead Managers), NZX participants, other approved financial intermediaries and institutional investors. The offer will close on 10 May 2023 following the completion of the bookbuild process.
Interested investors should contact the Joint Lead Managers or their usual financial adviser for more details.
Ends
No comments yet
December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors